Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence.  Pourebrahim S, Ahmad T, Rottmann E, Schulze J, Scheller B.  Biomolecules. 2025 Mar 4;15(3):368. doi: 10.3390/biom15030368. PMID: 4014…

The Pharmacology of Cannabinoids in Chronic Pain.  Cortez-Resendiz A, Leiter TJ, Riela SM, Graziane NM, Raup-Konsavage WM, Vrana KE.  Med Cannabis Cannabinoids. 2025 Feb 5;8(1):31-46. doi: 10.1159/000543813. PMID: 40046175; PMCID: PMC118…

Cannabinoid Hyperemesis Syndrome: A Rising Complication. Peles S, Khalife R, Magliocco A.  Cureus. 2025 Feb 13;17(2):e78958. doi: 10.7759/cureus.78958. PMID: 40091958; PMCID: PMC11910202. https://pmc.ncbi.nlm.nih.gov/articles/PMC11910202/

Cannabis use disorder: an overview of treatment approaches in Europe.  Hoch, E., Murawski, M., Ferri, M. et al. Eur Arch Psychiatry Clin Neurosci 275, 315–326 (2025). doi.org/10.1007/s00406-025-01964-7 https://link.springer.com/art…

Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning.  Jayawardhana J, Hou J, Freeman P, Talbert JC.  JAMA Psychiatry. Published online December 23, 2024. doi:10.1001/jamapsychi…

Cancer risk and legalisation of access to cannabis in the USA: overview of the evidence Nargis, Nigar et al. The Lancet Public Health, Volume 0, Issue 0  https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00223-8/fulltexthttp…